Literature DB >> 23797207

Longitudinal changes in total body creatine pool size and skeletal muscle mass using the D3-creatine dilution method.

Stephen A Stimpson1, Michael S Leonard, Lisa G Clifton, James C Poole, Scott M Turner, Todd W Shearer, Katja S Remlinger, Richard V Clark, Marc K Hellerstein, William J Evans.   

Abstract

BACKGROUND: We recently validated in cross-sectional studies a new method to determine total body creatine pool size and skeletal muscle mass based on D3-creatine dilution from an oral dose and detection of urinary creatinine enrichment by isotope ratio mass spectrometry (IRMS). Routine clinical use of the method in aging and disease will require repeated application of the method, with a more widely available technology than IRMS, to enable determination of change in skeletal muscle mass in longitudinal studies. We therefore adapted the method to liquid chromatography-tandem mass spectrometry (LC-MS/MS) technology, and sought to establish proof of concept for the repeated application of the method in a longitudinal study. Because the turnover of creatine is slow, it was also critical to determine the impact of background enrichment from an initial dose of oral D3-creatine on subsequent, longitudinal measurements of change in muscle mass.
METHODS: Rats were given an oral tracer dose of D3-creatine (1.0 mg/kg body weight) at 10 and 17 weeks of age. LC-MS/MS was used to determine urinary D3-creatine, and urinary D3-creatinine enrichment, at time intervals after D3-creatine administration. Total body creatine pool size was calculated from urinary D3-creatinine enrichment at isotopic steady state 72 h after administration of D3-creatine tracer.
RESULTS: At 10 weeks of age, rat lean body mass (LBM) measured by quantitative magnetic resonance correlated with creatine pool size (r = 0.92, P = 0.0002). Over the next 7 weeks, the decline in urinary D3-creatinine enrichment was slow and linear, with a rate constant of 2.73 ± 0.06 %/day. Subtracting background urinary D3-creatinine enrichment from the elevated enrichment following a second dose of D3-creatine at 17 weeks permitted repeat calculations of creatine pool size. As at 10 weeks, 17-week LBM correlated with creatine pool size (r = 0.98, P <0.0001). In addition, the change in creatine pool size was correlated with the change in LBM during the 7 weeks of rat growth between measurements (r = 0.96, P <0.0001).
CONCLUSION: The LC-MS/MS-based D3-creatine dilution method can be applied repeatedly to measure total body creatine skeletal muscle mass change in longitudinal study.

Entities:  

Year:  2013        PMID: 23797207      PMCID: PMC3774916          DOI: 10.1007/s13539-013-0110-1

Source DB:  PubMed          Journal:  J Cachexia Sarcopenia Muscle        ISSN: 2190-5991            Impact factor:   12.910


  10 in total

1.  The hydrolysis of phosphocreatine and the origin of urinary creatinine.

Authors:  H BORSOOK; J W DUBNOFF
Journal:  J Biol Chem       Date:  1947-05       Impact factor: 5.157

2.  The effect of methyltestosterone on the rate of synthesis of creatine.

Authors:  H D HOBERMAN; E A H SIMS; W W ENGSTROM
Journal:  J Biol Chem       Date:  1948-03       Impact factor: 5.157

3.  Creatine and creatinine metabolism in the normal male adult studied with the aid of isotopic nitrogen.

Authors:  H D HOBERMAN; E A H SIMS; J H PETERS
Journal:  J Biol Chem       Date:  1948-01       Impact factor: 5.157

4.  Total-body creatine pool size and skeletal muscle mass determination by creatine-(methyl-D3) dilution in rats.

Authors:  Stephen A Stimpson; Scott M Turner; Lisa G Clifton; James C Poole; Hussein A Mohammed; Todd W Shearer; Greg M Waitt; Laura L Hagerty; Katja S Remlinger; Marc K Hellerstein; William J Evans
Journal:  J Appl Physiol (1985)       Date:  2012-03-15

Review 5.  Creatine: biosynthesis, regulation, and function.

Authors:  J B Walker
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1979

6.  Muscle mass determination by isotopic dilution of creatine-14C.

Authors:  C K Meador; R A Kreisberg; J P Friday; B Bowdoin; P Coan; J Armstrong; J B Hazelrig
Journal:  Metabolism       Date:  1968-12       Impact factor: 8.694

7.  Measurement of muscle mass in humans by isotopic dilution of creatine-14C.

Authors:  R A Kreisberg; B Bowdoin; C K Meador
Journal:  J Appl Physiol       Date:  1970-03       Impact factor: 3.531

8.  Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method.

Authors:  S B Heymsfield; C Arteaga; C McManus; J Smith; S Moffitt
Journal:  Am J Clin Nutr       Date:  1983-03       Impact factor: 7.045

Review 9.  Creatine and creatinine metabolism.

Authors:  M Wyss; R Kaddurah-Daouk
Journal:  Physiol Rev       Date:  2000-07       Impact factor: 37.312

10.  Creatine metabolism in skeletal muscle. II. creatine kinetics in man.

Authors:  C D Fitch; D D Lucy; J H Bornhofen; G V Dalrymple
Journal:  Neurology       Date:  1968-01       Impact factor: 9.910

  10 in total
  24 in total

1.  Total body skeletal muscle mass: estimation by creatine (methyl-d3) dilution in humans.

Authors:  Richard V Clark; Ann C Walker; Robin L O'Connor-Semmes; Michael S Leonard; Ram R Miller; Stephen A Stimpson; Scott M Turner; Eric Ravussin; William T Cefalu; Marc K Hellerstein; William J Evans
Journal:  J Appl Physiol (1985)       Date:  2014-04-24

Review 2.  Stable isotope tracers and exercise physiology: past, present and future.

Authors:  Daniel J Wilkinson; Matthew S Brook; Kenneth Smith; Philip J Atherton
Journal:  J Physiol       Date:  2016-10-09       Impact factor: 5.182

3.  The Importance of Muscle Versus Fat Mass in Sarcopenic Obesity: A Re-evaluation Using D3-Creatine Muscle Mass Versus DXA Lean Mass Measurements.

Authors:  Eric S Orwoll; Katherine E Peters; Marc Hellerstein; Steven R Cummings; William J Evans; Peggy M Cawthon
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-06-18       Impact factor: 6.053

4.  The Combined Oral Stable Isotope Assessment of Muscle (COSIAM) reveals D-3 creatine derived muscle mass as a standout cross-sectional biomarker of muscle physiology vitality in older age.

Authors:  Jessica Cegielski; Matthew S Brook; Bethan E Phillips; Catherine Boereboom; Amanda Gates; John F R Gladman; Kenneth Smith; Daniel J Wilkinson; Philip J Atherton
Journal:  Geroscience       Date:  2022-03-18       Impact factor: 7.713

5.  Creatine ( methyl-d3) dilution in urine for estimation of total body skeletal muscle mass: accuracy and variability vs. MRI and DXA.

Authors:  Richard V Clark; Ann C Walker; Ram R Miller; Robin L O'Connor-Semmes; Eric Ravussin; William T Cefalu
Journal:  J Appl Physiol (1985)       Date:  2017-08-31

6.  Circulating protein synthesis rates reveal skeletal muscle proteome dynamics.

Authors:  Mahalakshmi Shankaran; Chelsea L King; Thomas E Angel; William E Holmes; Kelvin W Li; Marc Colangelo; John C Price; Scott M Turner; Christopher Bell; Karyn L Hamilton; Benjamin F Miller; Marc K Hellerstein
Journal:  J Clin Invest       Date:  2015-12-14       Impact factor: 14.808

7.  Strong Relation Between Muscle Mass Determined by D3-creatine Dilution, Physical Performance, and Incidence of Falls and Mobility Limitations in a Prospective Cohort of Older Men.

Authors:  Peggy M Cawthon; Eric S Orwoll; Katherine E Peters; Kristine E Ensrud; Jane A Cauley; Deborah M Kado; Marcia L Stefanick; James M Shikany; Elsa S Strotmeyer; Nancy W Glynn; Paolo Caserotti; Mahalakshmi Shankaran; Marc Hellerstein; Steven R Cummings; William J Evans
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-05-16       Impact factor: 6.053

Review 8.  Body Composition Measurements from Birth through 5 Years: Challenges, Gaps, and Existing & Emerging Technologies-A National Institutes of Health workshop.

Authors:  Dympna Gallagher; Aline Andres; David A Fields; William J Evans; Robert Kuczmarski; William L Lowe; Julie C Lumeng; Emily Oken; John A Shepherd; Shumei Sun; Steven B Heymsfield
Journal:  Obes Rev       Date:  2020-04-20       Impact factor: 9.213

Review 9.  Emerging biomarkers in heart failure and cardiac cachexia.

Authors:  Goran Loncar; Daniel Omersa; Natasa Cvetinovic; Aleksandra Arandjelovic; Mitja Lainscak
Journal:  Int J Mol Sci       Date:  2014-12-22       Impact factor: 5.923

10.  Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies.

Authors:  Nicole Ebner; Lisa Steinbeck; Wolfram Doehner; Stefan D Anker; Stephan von Haehling
Journal:  J Cachexia Sarcopenia Muscle       Date:  2014-03-05       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.